ORCA BIO
Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients. Orca Bio has developed a pipeline of proprietary technologies that have the potential to impact over 100 malignant and auto-immune diseases. Orca has assembled a team of world-leading experts and technologists to execute this vision.
ORCA BIO
Industry:
Health Care Medical Pharmaceutical
Founded:
2016-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.orcabio.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
192 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Global Site Tag
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Osteal Therapeutics
Osteal Therapeutics is a clinical stage specialty pharmaceutical company developing novel treatments for orthopedic infections.
Portal Instruments
Portal Instruments is an early stage company that offers medical device.
Scilex Pharmaceuticals
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
TOT BIOPHARM
TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs.
Truepill
Truepill provides an API-connected healthcare infrastructure designed to revolutionize the patient experience.
Current Advisors List
Current Employees Featured
Founder
Investors List
Lightspeed Venture Partners
Lightspeed Venture Partners investment in Series D - Orca Bio
Dream Variation Ventures
Dream Variation Ventures investment in Series D - Orca Bio
Blue Chip Venture Company
Blue Chip Venture Company investment in Series D - Orca Bio
IMRF
IMRF investment in Series D - Orca Bio
DCVC Bio
DCVC Bio investment in Series D - Orca Bio
Kaiser Family Foundation
Kaiser Family Foundation investment in Series D - Orca Bio
Mubadala
Mubadala investment in Series D - Orca Bio
8VC
8VC investment in Series D - Orca Bio
Kaiser Permanente
Kaiser Permanente investment in Series D - Orca Bio
+ND Capital
+ND Capital investment in Series D - Orca Bio
Official Site Inspections
http://www.orcabio.com Semrush global rank: 5.1 M Semrush visits lastest month: 1.6 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Orca Bio"
Who We Are - Orca Bio
Read Ivan's bio Ivan launched Orca Bio in 2016 and is Chief Executive Officer of Orca Bio. He is also cofounder and former Chief Technology Officer of Lucira Health, a molecular diagnostics company that received the first FDA …See details»
Orca Bio Company Profile 2024: Valuation, Funding
Orca Bio General Information Description. Developer of cell therapy products designed to replace patients' diseased blood and immune systems with healthy ones. The company specializes in the research and development of novel cell …See details»
Join Our Team - Orca Bio
Since our founding, Orca Bio's leadership team has delivered on its mission, swiftly advancing our investigational therapies from their foundational science into the clinicSee details»
Orca Bio - Crunchbase Company Profile & Funding
Contact Email [email protected] Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients. Orca Bio has developed a pipeline of proprietary technologies that have the potential to …See details»
Working At Orca Bio: Company Overview and Culture - Zippia
Mar 14, 2024 orcabio.com. Organization Type. Private. Social Media. Orca Bio is helping to deliver the promise of cell therapy to patients without compromise. Based in Menlo Park, CA, …See details»
Orca Bio Expands in Greater Sacramento Building New
Sep 8, 2022 For more information, visit www.orcabio.com and follow Orca Bio on Twitter: @orcabio. ... The organization spearheads community-led direction to retain, attract, grow and …See details»
Orca Bio to Present Positive Clinical Data on Orca-T at the 50th …
MENLO PARK, Calif., April 11, 2024--Orca Bio, a late-stage biotechnology company developing high-precision cell therapies for the treatment of cancer, autoimmune diseases and genetic …See details»
Orca Bio Emerges With Nearly $300 Million to Transform …
Jun 17, 2020 The financing will support the continued advancement of Orca Bio’s cell therapy pipeline and its novel manufacturing platform, which sorts blood with single-cell precision and …See details»
Orca Bio Expands in Greater Sacramento Building New State-of …
Sep 8, 2022 – The 100,000-square-foot facility is located in Metro Air Park, Sacramento – Orca Bio, a late-stage biotechnology company developing high-precision cell therapies for the …See details»
What We Do - Orca Bio
Our investigational cell therapies are designed to replace a patient's cancerous blood and immune system with a healthy one, with the goal of improving survival rates and quality of life for survivors.See details»
Orca Bio Presents Positive Data Demonstrating the Potential for …
Dec 9, 2023 The full ASH presentations will be made available on www.orcabio.com. About Orca-T Orca-T is an investigational high-precision allogeneic cell therapy being evaluated in …See details»
Orca Bio Emerges With Nearly $300 Million to Transform
Jun 17, 2020 Company aims to safely and effectively regenerate a healthy blood and immune system for patients with hematological malignancies, genetic diseases and...See details»
Orca Bio Receives Regenerative Medicine Advanced Therapy
MENLO PARK, Calif., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Orca Bio, a clinical-stage biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) …See details»
Orca Bio Emerges With Nearly $300 Million to Transform …
Jun 17, 2020 Company aims to safely and effectively regenerate a healthy blood and immune system for patients with hematological malignancies, genetic diseases and autoimmune …See details»
Orca Bio Presents Promising Data on Orca-T in Two Oral …
Feb 23, 2024 MENLO PARK, Calif., February 23, 2024--Orca Bio, a late-stage biotechnology company developing high-precision cell therapies for the treatment of cancer, autoimmune …See details»
Orca Bio Expands in Greater Sacramento Building New State-of …
Sep 8, 2022 For more information, visit www.orcabio.com and follow Orca Bio on Twitter: @orcabio. About the Greater Sacramento Economic Council The Greater Sacramento …See details»
Orca Bio Emerges With Nearly $300 Million to Transform
Jun 17, 2020 For more information, please visit www.orcabio.com. Media Contact: [email protected]. Twitter; LinkedIn; Facebook; Email Print IPO. LATEST. FDA Tracker. …See details»
Orca Bio | Menlo Park CA - Facebook
Orca Bio, Menlo Park, California. 805 likes. Transforming allogeneic cell therapy for patients with blood cancer, genetic diseases and autoimmune disordersSee details»
Newsroom - Orca Bio
Jan 3, 2024 Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatment to Additional Patient Groups at the 65th ASH Annual MeetingSee details»